Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aripiprazole”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07215884
What this trial is testing

Dopamine and Sensorimotor Function in Stuttering

Who this might be right for
Stuttering, Adult
University of California, San Francisco 25
Early research (Phase 1)Study completedNCT00689559
What this trial is testing

Drug Interaction Study Between AZD3480 and Aripiprazole in Healthy Subjects

Who this might be right for
Alzheimer's Disease
AstraZeneca 52
Large-scale testing (Phase 3)Study completedNCT00683852
What this trial is testing

A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy

Who this might be right for
Major Depressive Disorder
Massachusetts General Hospital 225
Large-scale testing (Phase 3)Study completedNCT03172871
What this trial is testing

Aripiprazole IM Depot in the Acute Treatment of Adults With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Beijing Research Institute 436
Post-approval studies (Phase 4)Ended earlyNCT04203056
What this trial is testing

Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode

Who this might be right for
SchizophreniaSchizoaffective Disorder, Depressive TypeSchizophreniform Disorder
University of California, Los Angeles 15
Testing effectiveness (Phase 2)UnknownNCT02630888
What this trial is testing

Efficacy of Memantine add-on in the Treatment of Bipolar Disorder (Type I) Nonresponders or Partial Responders Patients

Who this might be right for
Bipolar Disorder
University of Sao Paulo 44
Not applicableUnknownNCT00752960
What this trial is testing

DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics

Who this might be right for
Psychoses
Genomas, Inc 1,000
Post-approval studies (Phase 4)Study completedNCT00320671
What this trial is testing

Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis

Who this might be right for
Schizophrenia
Northwell Health 198
Post-approval studies (Phase 4)Study completedNCT01822730
What this trial is testing

A Comparison of Paliperidone and Risperidone for Treatment of Patirnts With Methamphetamine-Associated Psychosis

Who this might be right for
Methamphetamine Dependence
Wei Hao 120
Large-scale testing (Phase 3)Study completedNCT00036114
What this trial is testing

Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Disease
Otsuka Pharmaceutical Development & Commercialization, Inc.
Post-approval studies (Phase 4)Study completedNCT00545467
What this trial is testing

Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents

Who this might be right for
DSM-IV SchizophreniaSchizoaffective Disorder
National Taiwan University Hospital 79
Not applicableStudy completedNCT02897167
What this trial is testing

Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients

Who this might be right for
SchizophreniaMental DisordersPsychotic Disorders
Fundación Marques de Valdecilla 150
Post-approval studies (Phase 4)WithdrawnNCT05554627
What this trial is testing

VA Aripiprazole vs Esketamine for Treatment Resistant Depression

Who this might be right for
Depressive Disorder, Major
VA Office of Research and Development
Early research (Phase 1)Study completedNCT00321516
What this trial is testing

Drug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I Disorder

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT00174876
What this trial is testing

Aripiprazole as Augmentation for TRD

Who this might be right for
Depression
State University of New York - Upstate Medical University 20
Post-approval studies (Phase 4)Study completedNCT00304616
What this trial is testing

SWitching to Abilify Trial (SWAT)

Who this might be right for
Schizophrenia
Korea Otsuka Pharmaceutical Co., Ltd. 500
Post-approval studies (Phase 4)Study completedNCT00345033
What this trial is testing

Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With Schizophrenia

Who this might be right for
SchizophreniaInsulin Resistance
Massachusetts General Hospital 38
Post-approval studies (Phase 4)Study completedNCT00198198
What this trial is testing

Aripiprazole Treatment of Bipolar Depression

Who this might be right for
Bipolar Depression
Indiana University 10
Large-scale testing (Phase 3)Ended earlyNCT01328093
What this trial is testing

A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients

Who this might be right for
Schizophrenia
Denovo Biopharma LLC 678
Early research (Phase 1)UnknownNCT00089440
What this trial is testing

Assessment of Interactions Between Methamphetamine and Aripiprazole - 1

Who this might be right for
Amphetamine-Related Disorders
National Institute on Drug Abuse (NIDA) 17
Next Page